In a position paper sent to the national parliament on Thursday 20 November, the Netherlands argues in favour of an ambitious ‘EU Biotech Act’ covering all biotechnology sectors: medical, agri-food, industrial and environmental (see EUROPE B13673A13).
The European Commission is due to present this legislative package in two parts. The first, expected in December, will focus on healthcare, particularly clinical trials (see EUROPE B13710A5). ‘Biotech Act II’ will focus more on...